FindTrial
Sign In

Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous bronchoalveolar lavage fluid in HIV-infected adults: a prospective cohort study

Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous bronchoalveolar lavage fluid in HIV-infected adults: a prospective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014792
Enrollment
Unknown
Registered
2018-02-05
Start date
2018-02-05
Completion date
Unknown
Last updated
2018-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Immunodeficiency Virus/Tuberculosis

Interventions

Gold Standard:MGIT culture
Index test:Xpert MTB/Rif Ultra

Sponsors

The Third People's Hospital of Shenzhen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Eligible participants aged 18 years to 65 years; CD4 lymphocyte count lowwer than 350 cells/mm3; with Human Immunodeficiency Virus (HIV) complicated by pulmonary infection.

Exclusion criteria

Exclusion criteria: HIV-negative participants or HIV-positive participants complicated by pulmonary infection were higher than 350 cells/mm3 CD4 lymphocyte count

Design outcomes

Primary

MeasureTime frame
Xpert MTB/Rif Ultra;—

Countries

China

Contacts

Public ContactPeize Zhang, Yang Zhou, Houming Liu

TheThird People's Hospital of Shenzhen

516472422@qq.com+86 13925236605

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026